Evidence map›Paper›PMID 34433239›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2021

Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity.

Heleen Demeyer, Divya Mohan, Chris Burtin, Anouk W Vaes, Matthew Heasley, Russell P Bowler, Richard Casaburi, Christopher B Cooper, Solange Corriol-Rohou, Anja Frei and 23 more

Abstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  4. Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Digital assessment of real-world walking in people with impaired mobility: How many hours and days are needed?The international journal of behavioral nutrition and physical activity · 2025
    Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Heleen DemeyerDepartment of Rehabilitation Sciences, KU Leuven-University of Leuven and Respiratory Division, University Hospitals Leuven, Leuven, Belgium.
Divya MohanMedical Innovation, Value Evidence and Outcomes, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania, United States.
Chris BurtinReval Rehabilitation Research Center, Biomed Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Anouk W VaesDepartment of Research and Development, CIRO, Horn, Netherlands.
Matthew HeasleyDigital Biomarkers, GlaxoSmithKline Research and Development, Stevenage, United Kingdom.
Russell P BowlerNational Jewish Health, Denver, Colorado, United States.
Richard CasaburiRehabilitation Clinical Trials Center, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
Christopher B CooperDepartments of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California, United States.
Solange Corriol-RohouAstraZeneca Research and Development, Global Regulatory Excellence, Paris, France.
Anja FreiEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Alan HamiltonBoehringer Ingelheim Canada, Burlington, Ontario, Canada.
Nicholas S HopkinsonNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Niklas KarlssonBioPharmaceuticals Research and Development Digital Health, AstraZeneca, Gothenburg, Sweden.
William D-C ManNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Marilyn L MoyPulmonary, Critical Care, and Sleep Medicine Section, VA Boston Healthcare System, Boston, Massachusetts, United States.
Fabio PittaLaboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil.
Michael I PolkeyNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Milo PuhanEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Stephen I RennardDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States.
Carolyn L RochesterSection of Pulmonary, Critical Care and Sleep, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
Harry B RossiterRehabilitation Clinical Trials Center, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
Frank SciurbaDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pennsylvania, United States.
Sally SinghDepartment of Respiratory Science, University of Leicester, Leicester, United Kingdom.
Ruth Tal-SingerCOPD Foundation, COPD360 Research, Miami, Florida, United States.
Ioannis VogiatzisDepartment of Sport, Exercise, and Rehabilitation, Northumbria University, Newcastle, United Kingdom.
Henrik WatzPulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
Rob Van LummelMcRoberts B.V., The Hague, Netherlands.
Jeremy WyattActiGraph, LLC, Pensacola, Florida, United States.
Debora D MerrillCOPD Foundation, COPD360 Research, Miami, Florida, United States.
Martijn A SpruitReval Rehabilitation Research Center, Biomed Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Judith Garcia-AymerichISGlobal, Barcelona, Spain.
Thierry TroostersDepartment of Rehabilitation Sciences, KU Leuven-University of Leuven and Respiratory Division, University Hospitals Leuven, Leuven, Belgium.
Chronic Lung Disease Biomarker and Clinical Outcome Assessment Qualification Consortium Task Force on Physical Activity

Funding

Mechanism Underlying the Transduction of Epimutations from the Soma to the Male GermlineP50HD098593 · NICHD · UNIVERSITY OF NEVADA RENO · PI ZHOU, TONG · 2019 to 2024
$7.2M
Determinants of 5 Year Progression of Muscle Dysfunction and Inactivity in COPDGene Participants Diversity SupplementR01HL151452 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ADAMI, ALESSANDRA, ROSSITER, HARRY B · 2020 to 2023
$1.6M
AstraZenecaBoehringer IngelheimChiesiGlaxoSmithKlineNHLBI NIH HHS R01 HL151452NICHD NIH HHS P50 HD098593
6 · The paper itself

Abstract

Physical activity (PA) is of key importance for health among healthy persons and individuals with chronic obstructive pulmonary disease (COPD). PA has multiple dimensions that can be assessed and quantified objectively using activity monitors. Moreover, as shown in the published literature, variable methodologies have been used to date to quantify PA among individuals with COPD, precluding clear comparisons of outcomes across studies. The present paper aims to provide a summary of the available literature for the rationale behind using objectively measured PA and proposes a standardized methodology for assessment, including standard operating procedures for future research. The present paper, therefore, describes the concept of PA, reports on the importance of PA, summarizes the dimensions of PA, provides a standard operating procedure on how to monitor PA using objective assessments, and describes the psychometric properties of objectively measured PA. The present international task force recommends implementation of the standard operating procedure for PA data collection and reporting in the future. This should further clarify the relationship between PA and clinical outcomes, test the impact of treatment interventions on PA in individuals with COPD, and successfully propose a PA endpoint for regulatory qualification in the future.

Indexed as

accelerometerymethodologyPhysical activitystandardization

Identifiers

PMID34433239
PMCPMC8686852

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.